COLUMBIA, Md., June 27, 2017 -- WellDoc®, the leading digital health technology company revolutionizing chronic disease management, announced today its support of the American Diabetes Association (ADA) of Maryland’s “The Fabulous YOU!” program. The company is providing the third class of women involved in the program with access to its BlueStar® digital therapeutic for individuals living with type 2 diabetes.
“The Fabulous YOU!” is a year-long program providing fitness and educational classes and materials, cooking classes, and coaching to participants to teach them how to manage their diabetes. Over the past few years, program participants achieved a reduction in their A1C levels and lost up to 16 pounds as they learned integral techniques to manage their diabetes.
“We are happy to be a part of this program to support women living with diabetes that are in our own backyard in the State of Maryland,” said WellDoc’s Director of Clinical Innovation Janice MacLeod. “We feel BlueStar will be another integral tool in each participant’s tool belt to help guide them through the complicated journey of living type 2 diabetes.”
Ms. MacLeod is a Certified Diabetes Educator (CDE) and recently wrote a chapter in the new Nutrition Therapy text and served on the 2017 National Work Group updating the ADA/AADE DSMES National Standards, which were both released at the ADA 77th Scientific Sessions. She was also actively involved on the local board of ADA in Virginia. Ms. MacLeod is the past regional Association of American Diabetes Educators (AADE) president. In her role at WellDoc, she is responsible for partnering with the healthcare team to integrate digital therapeutics, like BlueStar, into clinical practice.
BlueStar is WellDoc’s FDA-cleared, proven digital therapeutic that provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. WellDoc’s clinical evidence shows a 1.7 to 2.0 point mean A1C reduction for adults living with type 2 diabetes who used BlueStar.
“We are most grateful to WellDoc for providing our ‘Fabulous YOU!’ program participants with BlueStar,” said ADA Maryland’s Area Executive Director David McShea. “WellDoc is a technology leader in the type 2 diabetes space, and we are thrilled to get BlueStar in the hands of each participant in our program’s third cohort.”
To support integration of BlueStar into the program, WellDoc representatives will visit the class and assist participants with the use of BlueStar.
About WellDoc®
WellDoc® is the leading digital health company revolutionizing chronic disease management to help transform lives. Our groundbreaking technology is guiding individuals through the complicated journey of living with chronic diseases, with a goal of improving their health and helping them to be more balanced. We are the first digital health company based on a life science business model, and our foundation is built on randomized clinical trials that demonstrate significant clinical outcomes. We have mastered diabetes management by taking an aggressive and innovative approach that utilizes sophisticated logic and precise algorithms, and integrates the most advanced mobile technology, behavioral insight, and diabetes education for those living with type 2 diabetes. Our FDA-cleared, proven digital therapeutic, BlueStar®, provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. Our clinical evidence shows a 1.7 to 2.0 point mean A1C reduction for adults living with type 2 diabetes who used BlueStar®. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.
About The American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.
Contacts: Juliette Bogus PressComm PR Tel: +410.980.5687 Email: [email protected] David McShea, American Diabetes Association, Executive Director Maryland [email protected]


Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Apple Turns 50: From Garage Startup to AI Crossroads
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



